Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Boehm

Showing results (171-180 of 208) with videos related to

Pageof 21
Sort By:
Investigational New Drugs|October 13, 2010
A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achieve a complete responseRobert M Rifkin, Andrew Greenspan, John F Schwerkoske, et al.
Clinical Breast Cancer|July 16, 2008
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancerDavid Loesch, Lina Asmar, Kristi McIntyre, et al.
Investigational New Drugs|May 14, 2008
Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinomaDennis L Carter, Lina Asmar, David Barrera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2009
Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapyG Sonpavde, P O Periman, D Bernold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2006
Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter studyD A Richards, K A Boehm, D M Waterhouse, et al.
Magma (New York, N.Y.)|February 24, 2001
Muscular dystrophy: from gene to patientJ C Hopkins, B L Bia, J G Crilley, et al.
Shock (Augusta, Ga.)|March 10, 2001
Chemokines and interleukin-18 are up-regulated in bronchoalveolar lavage fluid but not in serum of septic surgical ICU patientsG Mathiak, L F Neville, G Grass, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2014
TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO)V Grünwald, U Keilholz, A Boehm, et al.
Research Square|November 24, 2025
Measuring Research Engagement among Previously Incarcerated Persons and Other Carceral Stakeholders while Implementing Wastewater-based Surveillance for SARS-CoV-2 in Jails: A Mixed-Methods StudyVictoria M Brown, Alexandra E Kauffman, Amadin A Olotu, et al.
Neuropharmacology|December 17, 2017
New Cav2 calcium channel gating modifiers with agonist activity and therapeutic potential to treat neuromuscular diseaseMan Wu, Hayley V White, Blake A Boehm, et al.
Pageof 21

Showing results (171-180 of 208) with videos related to

Sort By:
Pageof 21
Investigational New Drugs|October 13, 2010
A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achieve a complete responseRobert M Rifkin, Andrew Greenspan, John F Schwerkoske, et al.
Clinical Breast Cancer|July 16, 2008
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancerDavid Loesch, Lina Asmar, Kristi McIntyre, et al.
Investigational New Drugs|May 14, 2008
Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinomaDennis L Carter, Lina Asmar, David Barrera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2009
Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapyG Sonpavde, P O Periman, D Bernold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2006
Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter studyD A Richards, K A Boehm, D M Waterhouse, et al.
Magma (New York, N.Y.)|February 24, 2001
Muscular dystrophy: from gene to patientJ C Hopkins, B L Bia, J G Crilley, et al.
Shock (Augusta, Ga.)|March 10, 2001
Chemokines and interleukin-18 are up-regulated in bronchoalveolar lavage fluid but not in serum of septic surgical ICU patientsG Mathiak, L F Neville, G Grass, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2014
TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO)V Grünwald, U Keilholz, A Boehm, et al.
Research Square|November 24, 2025
Measuring Research Engagement among Previously Incarcerated Persons and Other Carceral Stakeholders while Implementing Wastewater-based Surveillance for SARS-CoV-2 in Jails: A Mixed-Methods StudyVictoria M Brown, Alexandra E Kauffman, Amadin A Olotu, et al.
Neuropharmacology|December 17, 2017
New Cav2 calcium channel gating modifiers with agonist activity and therapeutic potential to treat neuromuscular diseaseMan Wu, Hayley V White, Blake A Boehm, et al.
Pageof 21